• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mindset Pharma Inc (OP:MSSTF)

N/A UNCHANGED
Last Price Updated: 3:55 PM EDT, Oct 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.5381
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic ↗
September 18, 2023
Clinical-stage biopharma company Reunion Neuroscience has received the FDA’s clearance on its Investigational New Drug (IND) application to begin a Phase 2 study of RE104, a novel serotonergic... 
Via Benzinga
News headline image
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More ↗
September 05, 2023
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety 
Via Benzinga

Performance

More News

Read More
News headline image
Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions ↗
August 31, 2023
Via Benzinga
News headline image
Terran Biosciences Steps Into 4-OH-DiPT Prodrug Arena With New Patent Application ↗
July 18, 2023
Via Benzinga
News headline image
Reunion Neuroscience On The Brink Of Going Private With Final Court Approval ↗
July 17, 2023
Via Benzinga
News headline image
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More ↗
July 04, 2023
Via Benzinga
News headline image
Reunion Neuroscience's Q4 And Full Year 2023 Financial Results, To Close Take-Private Deal In Q3 ↗
June 29, 2023
Via Benzinga
News headline image
UK Greenlights Phase 2 Clinical Trial On Mindset Pharma's Psilocin Drug For Major Depression ↗
June 27, 2023
Via Benzinga
News headline image
Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More ↗
May 01, 2023
Via Benzinga
News headline image
This Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protection ↗
April 26, 2023
Via Benzinga
News headline image
New Clinical MDMA And Psilocybin Batches Head To Flourishing Psychedelics Market ↗
April 25, 2023
Via Benzinga
News headline image
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More ↗
March 20, 2023
Via Benzinga
News headline image
Two Major Psychedelics Companies Take Novel Chemical Entity Patent Battle To Federal Court ↗
March 14, 2023
Via Benzinga
News headline image
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More ↗
March 13, 2023
Via Benzinga
News headline image
Australia Receives First Batch Of Clinical-Grade Psilocybin From Mindset Pharma And PharmAla ↗
March 06, 2023
Via Benzinga
News headline image
Silo Pharma, Mindset Pharma, Terran Biosciences Receive Psychedelic Treatments Patents, IP Portfolios Expanded ↗
February 03, 2023
Via Benzinga
News headline image
Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More ↗
January 25, 2023
Via Benzinga
News headline image
Search Is On For Psychedelic Patents & FDA Designations, 3 Companies Share News ↗
January 21, 2023
Via Benzinga
News headline image
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More ↗
November 21, 2022
Via Benzinga
News headline image
These Two Psychedelics Companies Team Up In An Exclusive Sales Deal, Here Are The Details ↗
November 16, 2022
Via Benzinga
News headline image
Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement
November 16, 2022
From PharmAla Biotech
Via GlobeNewswire
News headline image
EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo, Market Subverticals & Informal Guidance ↗
November 07, 2022
Via Benzinga
News headline image
European Psychedelics Research Group Nabs $2M In Seed Funding As Clinical Research Picks Up Speed ↗
October 11, 2022
Via Benzinga
News headline image
Psyched: CA's Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More ↗
October 07, 2022
Via Benzinga
News headline image
Next-Generation Psychedelics Shows Promise With Upcoming Clinical Trials ↗
October 07, 2022
Via Benzinga

Frequently Asked Questions

Is Mindset Pharma Inc publicly traded?
Yes, Mindset Pharma Inc is publicly traded.
What exchange does Mindset Pharma Inc trade on?
Mindset Pharma Inc trades on the OTC Traded
What is the ticker symbol for Mindset Pharma Inc?
The ticker symbol for Mindset Pharma Inc is MSSTF on the OTC Traded
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap